company background image
ACCD logo

Accolade NasdaqGS:ACCD Stock Report

Last Price

US$3.67

Market Cap

US$305.2m

7D

-7.6%

1Y

-48.7%

Updated

14 Oct, 2024

Data

Company Financials +

ACCD Stock Overview

Engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

ACCD fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Accolade, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accolade
Historical stock prices
Current Share PriceUS$3.67
52 Week HighUS$15.36
52 Week LowUS$3.35
Beta1.99
11 Month Change-13.85%
3 Month Change-7.09%
1 Year Change-48.74%
33 Year Change-90.55%
5 Year Changen/a
Change since IPO-87.64%

Recent News & Updates

Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover

Sep 09

Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Jun 29
Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Recent updates

Accolade: Consider Both Short-Term Revenue Outlook And Rumored Takeover

Sep 09

Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Jun 29
Slammed 50% Accolade, Inc. (NASDAQ:ACCD) Screens Well Here But There Might Be A Catch

Accolade: Mixed Guidance (Rating Downgrade)

Jun 28

Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Jun 05
Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet?

Accolade: Staying Bullish On Favorable Developments

Apr 05

Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Feb 17
Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

Jan 17

Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)

Jan 11

Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Jun 13
Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

May 02
Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Feb 05
An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Accolade: Inching Closer To Profitability

Oct 17

Accolade Q2 2023 Earnings Preview

Oct 05

Accolade: Fair And Reasonably Priced, But Needs More Time

Aug 09

Accolade Q1 2023 Earnings Preview

Jun 29

Accolade: Little Recent Applause

Mar 28

Accolade Impresses With Revenue Growth But Faces Operating Losses

Dec 16

Accolade: I May Add To My Position

Oct 18

Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 11
Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Accolade, Inc. 2021 Q4 - Results - Earnings Call Presentation

May 06

Shareholder Returns

ACCDUS HealthcareUS Market
7D-7.6%1.6%1.5%
1Y-48.7%7.7%33.1%

Return vs Industry: ACCD underperformed the US Healthcare industry which returned 7.7% over the past year.

Return vs Market: ACCD underperformed the US Market which returned 33.1% over the past year.

Price Volatility

Is ACCD's price volatile compared to industry and market?
ACCD volatility
ACCD Average Weekly Movement9.3%
Healthcare Industry Average Movement6.8%
Market Average Movement6.3%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: ACCD has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ACCD's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20072,400Raj Singhwww.accolade.com

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions.

Accolade, Inc. Fundamentals Summary

How do Accolade's earnings and revenue compare to its market cap?
ACCD fundamental statistics
Market capUS$305.24m
Earnings (TTM)-US$80.10m
Revenue (TTM)US$441.03m

0.7x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACCD income statement (TTM)
RevenueUS$441.03m
Cost of RevenueUS$228.29m
Gross ProfitUS$212.74m
Other ExpensesUS$292.84m
Earnings-US$80.10m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.99
Gross Margin48.24%
Net Profit Margin-18.16%
Debt/Equity Ratio49.4%

How did ACCD perform over the long term?

See historical performance and comparison